Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia

Delphine Verbeke; Olga Gielen; Kris Jacobs; Nancy Boeckx; Kim De Keersmaecker; Johan Maertens; Anne Uyttebroeck; Heidi Segers; Jan Cools

doi:10.1097/HS9.0000000000000310

Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia

Hemasphere. 2019 Oct 22;3(6):e310. doi: 10.1097/HS9.0000000000000310. eCollection 2019 Dec.

Authors

Delphine Verbeke^{1

2

3}, Olga Gielen^{1

2

3}, Kris Jacobs^{1

2

3}, Nancy Boeckx^{3

4

5}, Kim De Keersmaecker^{3

4}, Johan Maertens^{3

6

7}, Anne Uyttebroeck^{3

4

8}, Heidi Segers^{3

4

8}, Jan Cools^{1

2

3}

Affiliations

¹ Center for Human Genetics, KU Leuven, Leuven, Belgium.
² Center for Cancer Biology, VIB, Leuven, Belgium.
³ Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium.
⁴ Department of Oncology, KU Leuven, Leuven, Belgium.
⁵ Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium.
⁶ Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁷ Department of Hematology, UZ Leuven, Leuven, Belgium.
⁸ Department of Pediatric Oncology, UZ Leuven, Leuven, Belgium.

No abstract available